Literature DB >> 16159556

[Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference].

Javier P Gisbert1, Xavier Calvet, Fernando Gomollón, Joan Monés.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16159556     DOI： 10.1157/13078424

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN： 0025-7753            Impact factor:   1.725


× No keyword cloud information.
  7 in total

1.  Management of Helicobacter Pylori Infection and Effectiveness Rates in Daily Clinical Practice in Spain: 2010-2019.

Authors:  Inés Ariño Pérez; Samuel J Martínez-Domínguez; Enrique Alfaro Almajano; Patricia Carrera-Lasfuentes; Ángel Lanas
Journal:  Antibiotics (Basel)       Date:  2022-05-20

2.  [Clinical practice guideline on the management of patients with dyspepsia. Update 2012].

Authors:  Javier P Gisbert; Xavier Calvet; Juan Ferrándiz; Juan Mascort; Pablo Alonso-Coello; Mercè Marzo
Journal:  Aten Primaria       Date:  2012-10-01       Impact factor: 1.137

3.  Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection.

Authors:  Ji Hyun Lim; Dong Ho Lee; Seong Tae Lee; Nayoung Kim; Young Soo Park; Cheol Min Shin; In Sung Song
Journal:  World J Gastroenterol       Date:  2015-12-14       Impact factor: 5.742

4.  Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori.

Authors:  Javier P Gisbert; Xavier Calvet
Journal:  Clin Exp Gastroenterol       Date:  2012-03-13

5.  N-acetyl cysteine as an adjunct to standard anti-Helicobacter pylori eradication regimen in patients with dyspepsia: A prospective randomized, open-label trial.

Authors:  Mohammad Hassan Emami; Mehdi Zobeiri; Hojatolah Rahimi; Fariba Arjomandi; Hamed Daghagzadeh; Peyman Adibi; Jalal Hashemi
Journal:  Adv Biomed Res       Date:  2014-09-08

6.  Whole-genome sequencing of clarithromycin resistant Helicobacter pylori characterizes unidentified variants of multidrug resistant efflux pump genes.

Authors:  Akira Iwamoto; Toshihito Tanahashi; Rina Okada; Yukio Yoshida; Kaoru Kikuchi; Yoshihide Keida; Yoshiki Murakami; Lin Yang; Koji Yamamoto; Shin Nishiumi; Masaru Yoshida; Takeshi Azuma
Journal:  Gut Pathog       Date:  2014-06-26       Impact factor: 4.181

7.  Meta-analysis: High-dose vs. low-dose metronidazole-containing therapies for Helicobacter pylori eradication treatment.

Authors:  Yingjie Ji; Hong Lu
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.